These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1380788)

  • 1. L-696,229 specifically inhibits human immunodeficiency virus type 1 reverse transcriptase and possesses antiviral activity in vitro.
    Goldman ME; O'Brien JA; Ruffing TL; Nunberg JH; Schleif WA; Quintero JC; Siegl PK; Hoffman JM; Smith AM; Emini EA
    Antimicrob Agents Chemother; 1992 May; 36(5):1019-23. PubMed ID: 1380788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral resistance to human immunodeficiency virus type 1-specific pyridinone reverse transcriptase inhibitors.
    Nunberg JH; Schleif WA; Boots EJ; O'Brien JA; Quintero JC; Hoffman JM; Emini EA; Goldman ME
    J Virol; 1991 Sep; 65(9):4887-92. PubMed ID: 1714522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyridinone derivatives: specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity.
    Goldman ME; Nunberg JH; O'Brien JA; Quintero JC; Schleif WA; Freund KF; Gaul SL; Saari WS; Wai JS; Hoffman JM
    Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6863-7. PubMed ID: 1713693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of 2-pyridinone derivatives as HIV-1-specific reverse transcriptase inhibitors. 2. Analogues of 3-aminopyridin-2(1H)-one.
    Saari WS; Wai JS; Fisher TE; Thomas CM; Hoffman JM; Rooney CS; Smith AM; Jones JH; Bamberger DL; Goldman ME
    J Med Chem; 1992 Oct; 35(21):3792-802. PubMed ID: 1279173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of N3-methyl derivative of 3'-azido-3'-deoxythymidine 5'-triphosphate on the activity of HIV-1 reverse transcriptase.
    Nakane H; Suzuki A; Nakata Y; Kitade Y; Hirota K; Maki Y; Ono K
    Nucleic Acids Symp Ser; 1991; (25):27-8. PubMed ID: 1726810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamic studies (PD) of didanosine (ddI) alone and in combination with azidothymidine (AZT) in human T-cells; a stochastic biochemical approach to antiretroviral nucleoside drug combination in inhibiting HIV-reverse transcriptase (RT).
    Periclou AP; Nandy P; Avramis VI
    In Vivo; 2000; 14(3):377-88. PubMed ID: 10904870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azidothymidine triphosphate is an inhibitor of both human immunodeficiency virus type 1 reverse transcriptase and DNA polymerase gamma.
    König H; Behr E; Löwer J; Kurth R
    Antimicrob Agents Chemother; 1989 Dec; 33(12):2109-14. PubMed ID: 2482702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective and synergistic inhibition of human immunodeficiency virus type 1 reverse transcriptase by a non-nucleoside inhibitor, MKC-442.
    Yuasa S; Sadakata Y; Takashima H; Sekiya K; Inouye N; Ubasawa M; Baba M
    Mol Pharmacol; 1993 Oct; 44(4):895-900. PubMed ID: 7694070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nonnucleoside reverse transcriptase inhibitor active on human immunodeficiency virus type 1 isolates resistant to related inhibitors.
    Goldman ME; O'Brien JA; Ruffing TL; Schleif WA; Sardana VV; Byrnes VW; Condra JH; Hoffman JM; Emini EA
    Antimicrob Agents Chemother; 1993 May; 37(5):947-9. PubMed ID: 7685996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective action of 4'-azidothymidine triphosphate on reverse transcriptase of human immunodeficiency virus type 1 and human DNA polymerases alpha and beta.
    Chen MS; Suttmann RT; Papp E; Cannon PD; McRoberts MJ; Bach C; Copeland WC; Wang TS
    Biochemistry; 1993 Jun; 32(23):6002-10. PubMed ID: 7685186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective interaction of the human immunodeficiency virus type 1 reverse transcriptase nonnucleoside inhibitor efavirenz and its thio-substituted analog with different enzyme-substrate complexes.
    Maga G; Ubiali D; Salvetti R; Pregnolato M; Spadari S
    Antimicrob Agents Chemother; 2000 May; 44(5):1186-94. PubMed ID: 10770750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymatic properties of two mutants of reverse transcriptase of human immunodeficiency virus type 1 (tyrosine 181-->isoleucine and tyrosine 188-->leucine), resistant to nonnucleoside inhibitors.
    Loya S; Bakhanashvili M; Tal R; Hughes SH; Boyer PL; Hizi A
    AIDS Res Hum Retroviruses; 1994 Aug; 10(8):939-46. PubMed ID: 7529032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus reverse transcriptase. Substrate and inhibitor kinetics with thymidine 5'-triphosphate and 3'-azido-3'-deoxythymidine 5'-triphosphate.
    Reardon JE; Miller WH
    J Biol Chem; 1990 Nov; 265(33):20302-7. PubMed ID: 1700787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of HIV-1 reverse transcriptase and its mutants to inhibition by azidothymidine triphosphate.
    Carroll SS; Geib J; Olsen DB; Stahlhut M; Shafer JA; Kuo LC
    Biochemistry; 1994 Mar; 33(8):2113-20. PubMed ID: 7509634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of HIV-1 reverse transcriptase by pyridinone derivatives. Potency, binding characteristics, and effect of template sequence.
    Carroll SS; Olsen DB; Bennett CD; Gotlib L; Graham DJ; Condra JH; Stern AM; Shafer JA; Kuo LC
    J Biol Chem; 1993 Jan; 268(1):276-81. PubMed ID: 7677997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the anti-HIV-1 activity of 3,4-dihydro-2-alkoxy-6-benzyl-4-oxopyrimidines (DABOs), new non-nucleoside reverse transcriptase inhibitors.
    Tramontano E; Marongiu ME; de Montis A; Loi AG; Artico M; Massa S; Mai A; la Colla P
    New Microbiol; 1994 Oct; 17(4):269-79. PubMed ID: 7532270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between 3'-azido-3'-deoxythymidine resistance and primer unblocking activity in foscarnet-resistant mutants of human immunodeficiency virus type 1 reverse transcriptase.
    Meyer PR; Matsuura SE; Zonarich D; Chopra RR; Pendarvis E; Bazmi HZ; Mellors JW; Scott WA
    J Virol; 2003 Jun; 77(11):6127-37. PubMed ID: 12743270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic inhibition of human immunodeficiency virus replication in vitro by combinations of 3'-azido-3'-deoxythymidine and 3'-fluoro-3'-deoxythymidine.
    Harmenberg J; Akesson-Johansson A; Vrang L; Cox S
    AIDS Res Hum Retroviruses; 1990 Oct; 6(10):1197-202. PubMed ID: 1701316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunodeficiency virus type 1 reverse transcriptase. 3'-Azidodeoxythymidine 5'-triphosphate inhibition indicates two-step binding for template-primer.
    Jaju M; Beard WA; Wilson SH
    J Biol Chem; 1995 Apr; 270(17):9740-7. PubMed ID: 7537269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced binding of azidothymidine-resistant human immunodeficiency virus 1 reverse transcriptase to the 3'-azido-3'-deoxythymidine 5'-monophosphate-terminated primer.
    Canard B; Sarfati SR; Richardson CC
    J Biol Chem; 1998 Jun; 273(23):14596-604. PubMed ID: 9603976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.